stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Dow:  
Nasdaq:  
S&P 500:  
Viking Therapeutics IncVKTX
$26.821.69%-0.46
Dopo l'orario di chiusura: 26.92+0.10 +0.37%

Viking Therapeutics Inc (VKTX)

Date: 2026-11-02 16:00O: 27.25H: 27.90L: 26.54C: 26.82Vol: 3.991M
Precedente Chiudi:
$27.28
Aprire:
$27.25
Volume 24 ore:
3,991,062
Volume relativo:
0.92
Capitalizzazione di mercato:
$3.42B
Reddito:
-
Utile/perdita netta:
-$472.34M
Rapporto P/E:
-
EPS:
-$4.15
Flusso di cassa netto:
-$340.33M
1W Prestazione:
+10.78%
1M Prestazione:
-10.42%
6M Prestazione:
-10.60%
1Y Prestazione:
-29.57%
Intervallo 1D:
$26.54$27.90
Intervallo di 1 settimana:
$23.82$27.90
Portata 52W:
$23.82$43.15

Profilo aziendale di Viking Therapeutics Inc (VKTX)

Nome
Viking Therapeutics Inc
Settore
Healthcare
Industria
Biotechnology
Telefono
858-704-4660
Indirizzo
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA, USA
Dipendente
53
Prossima data di guadagno
null
Ultimi documenti SEC
SEC
Discussioni di VKTX su X
X

Confronta VKTX con VRTX, REGN, MRNA, ARGX, ONC

AzioniCap. di mercatoRedditoReddito nettoFlusso di cassaEPS
VKTX
Viking Therapeutics Inc
$3.42B$0-$627.20M-$340.33M-$4.15
VRTX
Vertex Pharmaceuticals Inc
$140.94B$12.59B$4.41B$3.80B$16.87
REGN
Regeneron Pharmaceuticals Inc
$99.46B$16.90B$4.82B$3.83B$41.04
MRNA
Moderna Inc
$88.17B$2.23B-$3.15B-$1.24B-$8.15
ARGX
Argen X Se Adr
$55.03B$4.16B$1.29B$734.26M$19.58
ONC
Beone Medicines Ltd Adr
$40.86B$6.13B$655.71M$1.33B$4.48

Viking Therapeutics Inc Azioni (VKTX) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-10-15IniziatoUBSBuy
2026-05-28IniziatoLake StreetBuy
2026-05-27ResumedTruistBuy
2026-03-26IniziatoWolfe ResearchPeer Perform

Viking Therapeutics Inc Azioni (VKTX) Dati Finanziari

PeriodoAndamentoFY 2025FY 2024FY 2023FY 2022FY 2021
Data di fine periodo2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)0.000.000.000.000.00
Research and development USD (M)344.96101.6463.8154.2344.98
Operating expenses USD (M)393.34150.92100.8370.3655.68
Operating income USD (M)-393.34-150.92-100.83-70.36-55.68
Income before tax USD (M)-359.64--85.89-68.87-54.99
Income tax expense USD (M)0.000.000.000.000.00
Net income USD (M)-359.64-109.96-85.90-68.87-54.99
Basic EPS USD/shares-3.19-1.01-0.91-0.90-
Diluted EPS USD/shares-3.19-1.01-0.91-0.90-
Basic weighted shares shares (M)112.67109.0494.3576.83-
Diluted weighted shares shares (M)112.67109.0494.3576.83-

Viking Therapeutics Inc Azioni (VKTX) insider trading

  • Lian BrianJul 29 '26
    President & CEO
    Transazione
    Sale
    Costo
    $33.32
    #Azioni
    148,517
    Valore ($)
    4,947,888
    #Azioni Totale
    2,572,441
  • Officer
    Transazione
    Proposed Sale
    Costo
    $33.47
    #Azioni
    18,217
    Valore ($)
    609,636
    #Azioni Totale
    0
  • GREG ZANTEJul 29 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $33.47
    #Azioni
    21,217
    Valore ($)
    710,141
    #Azioni Totale
    0
  • BRIAN LIANJul 29 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $33.32
    #Azioni
    148,517
    Valore ($)
    4,947,888
    #Azioni Totale
    0
  • Chief Operating Officer
    Transazione
    Sale
    Costo
    $33.47
    #Azioni
    18,217
    Valore ($)
    609,636
    #Azioni Totale
    422,760
  • ZANTE GREGJul 29 '26
    Chief Financial Officer
    Transazione
    Sale
    Costo
    $33.47
    #Azioni
    21,217
    Valore ($)
    710,141
    #Azioni Totale
    212,204
  • Chief Commercial Officer
    Transazione
    Buy
    Costo
    $33.50
    #Azioni
    4,475
    Valore ($)
    149,912
    #Azioni Totale
    4,475
  • GREG ZANTEJan 05 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $32.98
    #Azioni
    57,661
    Valore ($)
    1,901,470
    #Azioni Totale
    0
  • BRIAN LIANJan 05 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $32.96
    #Azioni
    233,409
    Valore ($)
    7,692,134
    #Azioni Totale
    0
  • Officer
    Transazione
    Proposed Sale
    Costo
    $32.98
    #Azioni
    57,661
    Valore ($)
    1,901,406
    #Azioni Totale
    0
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
Lian BrianPresident & CEOJul 29 '26Sale$33.32148,5174,947,8882,572,441
MARIANNA MANCINIOfficerJul 29 '26Proposed Sale$33.4718,217609,6360
GREG ZANTEOfficerJul 29 '26Proposed Sale$33.4721,217710,1410
BRIAN LIANOfficerJul 29 '26Proposed Sale$33.32148,5174,947,8880
Mancini MariannaChief Operating OfficerJul 29 '26Sale$33.4718,217609,636422,760
ZANTE GREGChief Financial OfficerJul 29 '26Sale$33.4721,217710,141212,204
Aubuchon Neil WilliamChief Commercial OfficerMar 10 '26Buy$33.504,475149,9124,475
GREG ZANTEOfficerJan 05 '26Proposed Sale$32.9857,6611,901,4700
BRIAN LIANOfficerJan 05 '26Proposed Sale$32.96233,4097,692,1340
MARIANNA MANCINIOfficerJan 05 '26Proposed Sale$32.9857,6611,901,4060

Viking Therapeutics Inc Borsa (VKTX) Ultime notizie

07:49 AM
07:49 AM
07:22 AM
07:22 AM
07:22 AM
07:22 AM
Oct 31, 2026
Oct 31, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 27, 2026
Oct 27, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 25, 2026
Oct 25, 2026
Oct 25, 2026
Oct 25, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 22, 2026
Oct 22, 2026
Oct 22, 2026
Oct 22, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026

Simile a VKTX